HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under the provision of the Companies Act, VII of 1913. Its Shares are listed on two stock exchanges in India i.e Bombay Stock Exchange and National Stock Exchange. The company has decades of presence in the Indian Pharma market and a strong foothold in the international market.

Indoco has strengthened its wings in the international markets and offers complete solutions, including product development, manufacture and supply of Finished Dosages, APIs and Intermediates to generic companies worldwide. The company has a large basket of products backed by ANDAs / eCTD Dossiers and Drug Master Files (DMFs).

Expertise in Research & Development, backward integration in API in select products, own CRO set-up, excellence in Finished Dosages manufacturing and a strong customer base will ensure consistent growth in the Company’s Domestic, as well as International business.

Business area of the company

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets.

Indoco Remedies Ltd.

Marksans Pharma Ltd.

AMI Organics Ltd.

Advanced Enzyme Technologies Ltd.

Hikal Ltd.

Strides Pharma Science Ltd.

Aarti Drugs Ltd.

Wockhardt Ltd.

Neuland Laboratories Ltd.

Shilpa Medicare Ltd.

Dishman Carbogen Amcis Ltd.

Unichem Laboratories Ltd.

Gufic Biosciences Ltd.

Amrutanjan Health Care Ltd.

FDC Ltd.

Open Price	327.75	Volume	100
Prev. Close	327.75

Performance